Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 912

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 912
---
 | $ | 22,274 | ​ | ​ | ​ | ​               | $ | 8 | ​ | ​ | ​ | ​                | $ | -32 | ​ | ​ | ​ | ​          | $ | 22,250 | ​ | ​ |

The Company had net unrealized losses of approximately $24,000 during the year ended December 31, 2022. Upon maturity of all of the Company’s short-term investments during the year ended December 31, 2023, the Company reversed this loss. The Company did not have short-term investments during the year ended December 31, 2023. The contractual maturities of the Company’s short-term investments in available-for-sale securities held were as follows (in thousands):

| ​                   | ​ | ​ | December 31,2022 |   |        |   | ​ |
|:--------------------|:--|:--|:-----------------|:--|-------:|:--|:--|
| Due within one year | ​ | ​ | ​                | $ | 22,250 | ​ | ​ |

F-104

TABLE OF CONTENTS

4. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following as of December 31, 2023 and 2022 (in thousands):

| ​                                               
 ​                                               | ​ 
 ​ | ​ 
 ​ | As of December 31, 
 2023               |   |       |   | ​ | ​ | 2022 |   |     |   | ​ 
 ​ |
|:------------------------------------------------|:--|:--|:-------------------|:--|------:|:--|:--|:--|:-----|:--|----:|:--|:--|
| Prepaid research and development expenses       | ​ | ​ | ​                  | $ | 3,203 | ​ | ​ | ​ | ​    | $ | 314 | ​ | ​ |
| Other prepaid expenses                          | ​ | ​ | ​                  | ​ |    36 | ​ | ​ | ​ | ​    | ​ |  56 | ​ | ​ |
| Total prepaid expenses and other current assets | ​ | ​ | ​                  | $ | 3,239 | ​ | ​ | ​ | ​    | $ | 370 | ​ | ​ |

5. Intangible Assets Intangible assets consisted of the following as of December 31, 2023 and